Live feed08:30:00·23dPRReleasevia QuantisnowPropanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma ModelsByQuantisnow·Wall Street's wire, on your screen.PPCB· Propanc Biopharma Inc.Health Care
